Rivfloza
Generic name: Nedosiran
Dosage form: subcutaneous injection: 80 mg (0.5 mL) single-dose vial, 128 mg (0.8 mL) single-dose Pre-filled Syringe, 160 mg (1 mL) single-dose Pre-filled Syringe
Drug class:
Miscellaneous metabolic agents
Usage of Rivfloza
Rivfloza (nedosiran) is a medication used to lower urinary oxalate levels in specific patients with hyperoxaluria type 1 (PH1). Primary hyperoxaluria type 1 is a genetic disorder where there is an overproduction of oxalate, which results in too much oxalate in the urine and this causes kidney stones and chronic kidney disease, among other complications. Rivfloza works to lower oxalate levels by decreasing an enzyme (hepatic lactate dehydrogenase (LDH)) involved in making oxalate.
Rivfloza is an LDHA-directed small interfering RNA medicine. Rivfloza is usually given as an injection under the skin (suBCutaneously) once a month.
Rivfloza became an FDA-approved medicine on September 29, 2023, after positive results from a randomized, double-blind trial called PHYOX2. This trial assessed the average 24-hour urinary oxalate excretion at various intervals (90, 120, 150, and 180 days). Rivfloza reduced the urinary oxalate excretion level by 37%, and the placebo group levels increased by 12%, with the difference between the group being 49%.
Rivfloza side effects
Common Side Effects include:
These are not all the possible side effects of Rivfloza. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Novo Nordisk at 1-844-906-5099.
Before taking Rivfloza
Pregnancy
Tell your healthcare provider if you are pregnant or plan to become pregnant. There is not enough data from reports of pregnancy in clinical trials with Rivfloza to know if it will harm your unborn baby.
Breastfeeding
Tell your healthcare provider if you are breastfeeding or planning to breastfeed, as It is not known if Rivfloza passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with this injection.
Relate drugs
- Amvuttra
- Asfotase alfa
- Crysvita
- Myalept
- Burosumab
- Burosumab-twza
- Cerdelga
- Eliglustat
- Fosdenopterin
- Galafold
- Givlaari
- Givosiran
- Inotersen
- Kuvan
- Lonafarnib
- Lumasiran
- Metreleptin
- Migalastat
- Miglustat
- Mitapivat
- Nitisinone
- Nityr
- Nulibry
- Onpattro
- Opfolda
- Orfadin
- Oxlumo
- Palynziq
- Patisiran
- Pegvaliase
- Pegvaliase-pqpz
- Pyrukynd
- Pyrukynd Taper Pack
- Rivfloza
- Sapropterin
- Strensiq
- Tegsedi
- Vutrisiran
- Zavesca
- Zokinvy
How to use Rivfloza
Use Rivfloza exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets.
Rivfloza is usually given as an injection under the skin (subcutaneously) once a month.
Your healthcare provider will prescribe the dose that is right for you based on your body weight.
Rivfloza comes as a single-dose Pre-filled Syringe and a single-dose vial.
Your healthcare provider will show you how to prepare and inject this medicine.
Do not try to inject this medicine until you have been shown the right way by your healthcare provider.
For children 9 to 11 years of age weighing 110 pounds (50 kilograms) or more, it is recommended that the Pre-filled Syringe be given by a healthcare provider or caregiver.
Rivfloza Dosage forms and strengths
What other drugs will affect Rivfloza
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions